Education
About Us
Working with TipRanks
Follow Us
Concord Medical Services (CCM)
NYSE:CCM
RESEARCH TOOLSreports
Total Valuation
Concord Medical Services has a market cap or net worth of $28.76M. The enterprise value is $17.91B.
Market Cap$28.76M
Enterprise Value$17.91B
Share Statistics
Concord Medical Services has 2,815,458 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,815,458
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Concord Medical Services’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is -9.13%.
Return on Equity (ROE)0.14
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-9.13%
Return on Capital Employed (ROCE)-0.12
Revenue Per Employee645.30K
Profits Per Employee-1.10M
Employee Count595
Asset Turnover0.06
Inventory Turnover13.85
Valuation Ratios
The current PE Ratio of Concord Medical Services is -0.02. Concord Medical Services’s PEG ratio is 0.75.
PE Ratio-0.02
PS Ratio0.00
PB Ratio-7.95
Price to Fair Value>-0.01
Price to FCF-24.69
Price to Operating Cash Flow-68.41
PEG Ratio0.75
Income Statement
In the last 12 months, Concord Medical Services had revenue of 383.96M and earned -308.24M in profits. Earnings per share was -2.12K.
Revenue383.96M
Gross Profit-79.16M
Operating Income-532.16M
Pretax Income-669.58M
Net Income-308.24M
EBITDA-345.62M
Earnings Per Share (EPS)-2.12K
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Concord Medical Services pays an annual dividend of $9.8, resulting in a dividend yield of ―
Dividend Per Share$9.8
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.37
52-Week Price Change14.14%
50-Day Moving Average6.45
200-Day Moving Average5.68
Relative Strength Index (RSI)43.79
Average Volume (3m)20.84K
Important Dates
Concord Medical Services upcoming earnings date is Sep 27, 2024, TBA Not Confirmed.
Last Earnings DateSep 22, 2023
Next Earnings DateSep 27, 2024
Ex-Dividend DateDec 23, 2015
Financial Position
Concord Medical Services as a current ratio of 0.46, with Debt / Equity ratio of -173.82%
Current Ratio0.46
Quick Ratio0.45
Debt to Market Cap655.27
Net Debt to EBITDA-10.75
Interest Coverage Ratio-2.75
Taxes
In the past 12 months, Concord Medical Services has paid -17.50M in taxes.
Income Tax-17.50M
Effective Tax Rate0.03
Enterprise Valuation
Concord Medical Services EV to EBITDA ratio is -11.24, with an EV/FCF ratio of -4.81.
EV to Sales10.12
EV to EBITDA-11.24
EV to Free Cash Flow-4.81
EV to Operating Cash Flow-9.77
Balance Sheet
Concord Medical Services has $326.90M in cash and marketable securities with ¥3.56B in debt, giving a net cash position of $3.24B billion.
Cash & Marketable Securities$326.90M
Total Debt¥3.56B
Net Cash$3.24B
Net Cash Per Share$1.15K
Tangible Book Value Per Share$83.60
Margins
Gross margin is -32.28%, with operating margin of -138.60%, and net profit margin of -80.28%.
Gross Margin-32.28%
Operating Margin-138.60%
Pretax Margin-174.39%
Net Profit Margin-80.28%
EBITDA Margin-90.02%
EBIT Margin-124.07%
Analyst Forecast
The average price target for Concord Medical Services is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-29.82%
EPS Growth Forecast-2.57%